Multivariate analysis
| Factor . | Beta . | HR . | 95% CI . | P . | Points . |
|---|---|---|---|---|---|
| Continuous comorbidity index | 0.15 | 1.16 | 1.07-1.25 | <.001 | 1 |
| >2 BM blasts, % | 0.53 | 1.70 | 1.11-2.61 | .02 | 4 |
| Genotype | |||||
| ASXL1- and/or NRAS-mutated | 0.49 | 1.63 | 1.15-2.31 | .006 | 4 |
| Factor . | Beta . | HR . | 95% CI . | P . | Points . |
|---|---|---|---|---|---|
| Continuous comorbidity index | 0.15 | 1.16 | 1.07-1.25 | <.001 | 1 |
| >2 BM blasts, % | 0.53 | 1.70 | 1.11-2.61 | .02 | 4 |
| Genotype | |||||
| ASXL1- and/or NRAS-mutated | 0.49 | 1.63 | 1.15-2.31 | .006 | 4 |
Concordance index: 0.68; corrected: 0.67.